0
Avadel Pharmaceuticals plc Banner Image

Avadel Pharmaceuticals plc has reached its limit for free report views

Work for Avadel Pharmaceuticals plc? Upgrade Your Profile and unlock all your annual reports.

Avadel Pharmaceuticals plc

  • Ticker AVDL
    Exchange NASDAQ More
  • Industry Drug Manufacturers - Other More
  • Sector Healthcare More
Avadel Pharmaceuticals plc Logo Image
  • 201-500 Employees
  • Based in Dublin, Ireland
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is an emerging biopharmaceutical company. The Company’s primary focus is the development and potential FDA approval of FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy.
Avadel Pharmaceuticals plc

Most Recent Annual Report

Avadel Pharmaceuticals plc MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Avadel Pharmaceuticals plc has reached its limit for free report views.

Older/Archived Annual Reports